A study led by researchers in Australia and China researched the impact of healthy gut bacteria and cognitive decline in dementia and Alzheimer's Disease.
read moreIn a recent study, researchers showed that stress-sensitive neural circuits alter the gut microbiome by directly influencing duodenal glands.
read moreA new study in mice concludes that FMT can effectively relieve Type 1 Diabetes associated cognitive decline by reducing the gut–brain metabolic disorders and neuroinflammation, providing a potential therapeutic approach for diabetes-related brain disorders.
read moreFecal microbiota transplantation (FMT), significantly reduced recurrence of hepatic encephalopathy compared with placebo in patients with cirrhosis on standard-of-care treatment, results of a phase 2 randomized controlled trial show.
read moreResearchers from North Carolina State University have found that multiple species of Gardnerella, bacteria sometimes associated with bacterial vaginosis (BV) and pre-term birth, can coexist in the same vaginal microbiome. The findings add to the emerging picture of Gardnerella’s effects on human health.
read moreA new research study indicates the presence of specific bacteria in the eye microbiome is correlated with dry eye symptoms.
read moreA new study indicates the presence of specific microbiota strains can predict response to immune checkpoint blockade.
read moreA team of researchers found that the presence and abundance of certain gut bacteria varied with the participants’ emotional states. Those who reported higher levels of positive emotions had different bacterial compositions compared to those who reported higher levels of negative emotions.
read moreA new study shows that symptomatic infections with H. pylori after the age of 50 can be associated with an eleven percent increase in the risk of Alzheimer's disease. The risk increase peaks at 24 percent about a decade after the initial infection.
read moreA recent study evaluated stool samples of patients with severe COVID-19 infections in the ICU. Results demonstrated that these patients had lower microbiome diversity, indicating a potential biomarker of disease progression and severity.
read more
